Your session is about to expire
← Back to Search
mHealth Platform for Pediatric Cancer Survivorship (ECHOS2 Trial)
N/A
Waitlist Available
Led By Erika Waters, PhD, MPH
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from post-test survey to 1 month follow-up (expected to be about 1 month and 1 week)
Awards & highlights
ECHOS2 Trial Summary
This trial assesses an mHealth platform to motivate childhood cancer survivors to adhere to cardiac screening. Participants recruited from the Childhood Cancer Survivorship Study.
Who is the study for?
This trial is for adult survivors of childhood cancer who are at least 18 years old, were diagnosed with cancer before turning 18, and are two or more years post-cancer treatment. They must have had therapy that could affect the heart but haven't had a heart scan in the last five years and don't have a history of cardiomyopathy.Check my eligibility
What is being tested?
The study is testing an mHealth platform called CIAS designed to encourage childhood cancer survivors to adhere to cardiac screening guidelines. It's about seeing if this tech-based motivational tool can be integrated into their healthcare routine effectively.See study design
What are the potential side effects?
Since CIAS is a computerized intervention software rather than a medication, traditional physical side effects aren't expected. However, participants may experience psychological impacts from engaging with health-related content.
ECHOS2 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from post-test survey to 1 month follow-up (expected to be about 1 month and 1 week)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from post-test survey to 1 month follow-up (expected to be about 1 month and 1 week)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in health belief model (HBM) construct scale of knowledge about echocardiograms and the effects of their treatment on health
Change in movement toward screening
Change in self-determination theory (SDT) construct scale of autonomy, defined by the perceived choice of getting an echocardiogram
+2 moreSecondary outcome measures
Change in health belief model (HBM) construct scale intentions of getting echocardiogram
Change in health belief model (HBM) construct scale of overall self-efficacy of getting echocardiogram
Change in health belief model (HBM) construct scale of perceived barriers to getting echocardiogram
+9 moreECHOS2 Trial Design
1Treatment groups
Experimental Treatment
Group I: Computerized Intervention Authoring Software (CIAS)Experimental Treatment1 Intervention
Participants will be provided with a link to begin the study following consent, and the link will direct the participants to a baseline survey. At the end of the survey, participants will be automatically redirected to Computerized Intervention Authoring Software (CIAS). Participants will be encouraged to complete 2 sessions in CIAS, approximately 1 week apart. After completing the second session, CIAS will automatically redirect the participants to a post-test survey. Approximately 30 days after completing the second session, participants will be invited to complete a 30 day follow-up survey.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Computerized Intervention Authoring Software (CIAS)
2023
N/A
~80
Find a Location
Who is running the clinical trial?
Washington University School of MedicineLead Sponsor
1,937 Previous Clinical Trials
2,299,622 Total Patients Enrolled
St. Jude Children's Research HospitalOTHER
428 Previous Clinical Trials
5,306,540 Total Patients Enrolled
Erika Waters, PhD, MPHPrincipal InvestigatorWashington University School of Medicine
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have never had a heart condition called cardiomyopathy.You finished cancer treatment more than 2 years ago.You have received specific types of heart-damaging treatments.You were diagnosed with cancer when you were 17 years old or younger.
Research Study Groups:
This trial has the following groups:- Group 1: Computerized Intervention Authoring Software (CIAS)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What are the anticipated outcomes of this experiment?
"The primary aim of this clinical trial, which will run for approximately a week from baseline to post-test survey, is to assess the changes in self-determination theory (SDT) construct scale of competence when it comes to getting an echocardiogram. Additionally, secondary outcomes include assessments on health belief model (HBM) scales such as perceived severity of heart problems based on a 5 point Likert scale ranging from 1-5 with higher scores indicating greater seriousness; the number of perceived barriers associated with obtaining an echocardiogram measured between 6 and 30 with lower numbers correlating to fewer obstacles; and finally apprais"
Answered by AI
Are there any openings available for this experiment at the present?
"This study, which was uploaded to clinicaltrials.gov on July 31st 2023 is presently not recruiting patients. Although they are no longer searching for candidates, there are still 118 other trials actively enrolling individuals at this time according to the same database."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger